Catalyst Wire Dossier Catalyst Wire Dossier

Orvepitant

Orvepitant · Nerre Therapeutics Ltd.
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Orvepitant, covering 2017-08-04 to 2025-11-10. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis [Phase 2]

See pricing